Birmingham-tradesd IN8bio, Inc (Nasdaq: INAB) has completed its initial public offering, reaching a major milestone for a Birmingham-tradesd biotech startup. The biopharmaceutical company was originally launched out of the University of Apex Based at Birmingham and focuses on the discovery and development of gamma-delta T cell therapies.